Jagdish Gandhi And Another v. Satish B. Vaidya And Others

723027

The plaintiffs sought a declaration that they were the sole inventors and owners of an Ayurvedic formula (PV-150896) and claimed that the defendants had defrauded them. The court, while acknowledging the importance of the medicine for AIDS patients, dismissed the Notice of Motion at the interim stage due to the specialized nature of the dispute requiring extensive expert evidence.

Jurisdiction
India
Court / Office
Bombay High Court
Case Number
723027
Judge(s)
S.S. Nijjar

Detailed Summary

When a medicine promises hope to patients battling one of the world's most devastating diseases, the question of who owns the formula becomes more than just a legal technicality, it becomes a matter of life, legacy, and public trust. The dispute between Jagdish Gandhi and Satish B. Vaidya over an Ayurvedic formula designated PV-150896 is a striking example of how courts must tread carefully when private ownership claims collide with the urgent need for accessible healthcare. This case underscores a critical lesson for founders and innovators: the path from invention to enforceable rights is rarely straightforward, especially when the stakes involve public health.

The plaintiffs, Jagdish Gandhi and another party, approached the court asserting that they were the sole inventors and rightful owners of an Ayurvedic formula known as PV-150896, a medicine intended for AIDS patients. They alleged that the defendants, led by Satish B. Vaidya and others, had defrauded them in connection with this formula. The dispute centered on a deeply sensitive subject: a traditional medicine formulation that held promise for treating a condition with global health implications. Given the gravity of the claims and the potential impact on AIDS treatment, the matter demanded careful judicial scrutiny from the outset.

On one side, the plaintiffs argued that they were the true creators of the PV-150896 formula and that the defendants had wrongfully misappropriated or exploited their invention through fraudulent means. They sought judicial intervention to establish their exclusive ownership. On the other side stood the defendants, who contested the plaintiffs' claims of sole inventorship and ownership. The legal friction was compounded by the highly specialized nature of the subject matter, an Ayurvedic medicinal formula whose origins, development, and rightful attribution could not be resolved without deep technical and scientific examination. The court recognized that determining who truly invented the formula required extensive expert evidence, far beyond what could be assessed at an interim stage.

The court ultimately dismissed the Notice of Motion at the interim stage. While it acknowledged the immense importance of the medicine for AIDS patients and the seriousness of the allegations, it held that the specialized nature of the dispute necessitated thorough expert evaluation before any relief could be granted. The court could not, at the interim stage, make definitive findings on inventorship or ownership without the benefit of comprehensive expert testimony. The outcome meant that the plaintiffs' urgent plea for interim relief was denied, leaving the deeper questions of fraud and ownership to be resolved through a more exhaustive process.

For founders, researchers, and IP professionals, this case delivers a powerful reminder: when your invention sits at the intersection of public health and proprietary technology, courts will prioritize rigorous evidence over speed. Document every step of your invention process meticulously, from initial conception to formulation and testing. Secure ironclad records of inventorship before involving third parties, and understand that interim relief is rarely granted in highly technical disputes without substantial supporting evidence. Most importantly, recognize that when your work touches vulnerable populations, the legal system will demand an exceptionally high standard of proof before disrupting the status quo.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Bombay High Court. Understanding the court's reasoning in Jagdish Gandhi And Another vs Satish B. Vaidya And Others is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentCMA(PT) No. 22 of 2025

The North Face Apparel CorpvsController of Patents and Designs

The North Face Apparel Corp challenged the Controller of Patents' refusal of its patent application (No. 202147026139) titled 'Systems and Methods for End-to-End Article Management' before the Madras High Court under Section 117A of the Patents Act, 1970. The Controller had rejected the application citing lack of inventive step over prior art documents D21-D24. The Court held that the Controller erred by dissecting the claims into isolated elements rather than assessing the invention as a whole, and overlooked the use of spectrophotometer and invisible markers for tracking the manufacturing process, which were not disclosed in the cited prior art. The appeal was allowed and the Controller was directed to grant the patent.

patentCMA(PT) No. 62 of 2024

Aventose Energy Private LimitedvsThe Assistant Controller of Patents & Designs, Patent Office Chennai

Aventose Energy Private Limited appealed under Section 117A of the Patents Act, 1970 against the refusal of its patent application (No. 202141019671) for a 'System and Method for Operating Automobiles with an Electric Drivetrain' featuring safe mode activation upon fault detection. The Madras High Court found that the Assistant Controller had contradicted the First Examination Report (which accepted novelty) by subsequently holding the invention lacked novelty without giving the applicant an opportunity to be heard. The court further held that the Controller improperly conflated novelty with inventive step under Section 2(1)(ja) and failed to properly analyze the claims against prior art documents D1–D4.

patentOA Nos. 1108, 1109 & 1110 of 2026 in C.S(COMM DIV) No. 279 of 2026

Apex Laboratories Pvt LtdvsElder Lifescience and Ambico Ayurvedic Health Care

Apex Laboratories Pvt Ltd, the prior adopter and registered proprietor of the trademark ZINCOVIT (TM No. 487453 in Class 5) since 1988, sought interim injunction against Elder Lifescience and Ambico Ayurvedic Health Care for using the deceptively similar mark NEO ZINCOVIT. The applicant also claimed copyright infringement of its registered artistic works (A-108878/2014) covering colour scheme, get-up, and layout. The Madras High Court was satisfied that the respondents were attempting to piggyback on the applicant's goodwill and granted interim injunctions on all three applications covering trademark infringement, copyright infringement, and passing off.

patent

Radico Khaitan LimitedvsPicadilly Agro Industries Limited

This Special Leave Petition arose from a judgment dated 29-05-2026 in CS No. 8/2025 passed by the District Judge, Karnal, Haryana, concerning a trademark dispute over the marks 'Cashmere' and 'Kashmyr' used in relation to beer and vodka. The Supreme Court noted that a First Appeal (FAO-COM-11-2026) was already pending before the Division Bench of the Punjab and Haryana High Court, listed for 28.10.2026. The Court disposed of the SLP without adjudicating it on merits, requesting the High Court to pass an appropriate order regarding the ad interim injunction on the scheduled date.

patent

Maharaja Agrasen Technical Educational Society (Regd.)vsMaharaja Agrasen Himalayan Garhwal University

The plaintiff, Maharaja Agrasen Technical Educational Society, filed a suit for permanent injunction against the defendant, Maharaja Agrasen Himalayan Garhwal University, alleging infringement and passing off regarding the use of the words 'Maharaja Agrasen' in the defendant's name. The Delhi High Court had previously granted a restraint order on 10.07.2026. During the pendency of the suit, the parties arrived at a settlement dated 14.09.2026, under which the defendant agreed to change its name through a statutory amendment while being permitted limited transitional use of its existing name. The court recorded the settlement, modified the interim order accordingly, and listed the matter for compliance reporting on 13.07.2027.

patent

Varahi Diamonds And Finance LimitedvsSahil Vinay Mehra Trading As Mehra Sons Jewellers & Anr.

This is a commercial suit filed by Varahi Diamonds And Finance Limited against Sahil Vinay Mehra Trading As Mehra Sons Jewellers & Anr. before the Delhi High Court. The order is primarily procedural, dealing with the registration of the plaint, issuance of summons, directions for filing pleadings, and an interim injunction application. The matter was referred to mediation, with parties directed to appear before the Delhi High Court Mediation and Conciliation Centre.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call